SEC Form 4 · accession 0001437749-15-022678
VIVEVE MEDICAL, INC. · VIVE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jim B Robbins
Officer — Vice President of Finance
Period of report
Feb 17, 2015
Accepted (ET)
Dec 22, 2015 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000879682
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant to Purchase Common StockF1 | $0.50 | Feb 17, 2015 | A | 43,024 | A | Feb 17, 2015 | Feb 17, 2025 | Common Stock | 43,024 | 58,024 | D |
| Incentive Stock Options (Right to Purchase)F2,F3,F4,F5 | — | holding | — | — | — | — | — | Common Stock | — | 310,000 | D |
Explanation of responses
- F1The warrant was issued to the Reporting Person as bonus compensation.
- F2The Reporting Person received an option to purchase 116,000 shares of the Issuer's common stock on September 26, 2014 (the "2014 Option") and a second option to purchase 194,000 shares of the Issuer's common stock on December 16, 2015 (the "2015 Option"). The exercise price of the 2014 Option is $0.60 per share; the exercise price of the 2015 Option is $0.75 per share.
- F3The 2014 Option vests as follows: the right to purchase 1/4 of the option shares vested on June 30, 2015 and the right to purchase the remainder vests in increments of 1/48th per month thereafter. The 2015 Option vests over a period of four years beginning on the grant date in increments of 1/48th per month.
- F4The expiration date of the 2014 Option is September 26, 2024; the expiration date of the 2015 Option is December 16, 2025.
- F5The number of shares of common stock underlying the 2014 Option is 116,000 shares; the number of shares of common stock underlying the 2015 Option is 194,000 shares.